International Plasma Protein Congress

IPPC logo 2019 01

Every year, policymakers, regulators, industry leaders, physicians, scientists, and patient representatives from around the globe come together for the plasma protein therapeutics industry's premier European event the International Plasma Protein Congress (IPPC).

Save the date! IPPC 2020 will be held 1-2 October in Berlin.

 

Program

DAY ONE: 1 OCTOBER 2020

 0830-0900 Opening
  Welcome
Amy Efantis, President & CEO — PPTA

Keynote address
Martin Seychell, EU Commission, Deputy Director General, DG SANTE   (TBC)

0900-1045 Session 1 : Europe needs more plasma: Challenges and solutions
Chair: Peter O'Donnell, Freelance reporter — APM news / Politico

 

Miguel-Angel Vesga Carasa, Director General — Basque Transfusion Center, Spain  (TBC)

Matthew Hotchko, President — The Marketing Research Bureau

Nizar Mahlaoui, Pediatrician — Necker University Hospital for Children with Rare Disease, Paris (TBC)

Marie-Laure Hecquet, Head of the HealthCare Section — European Directorate for the Quality of Medicines & Healthcare (EDQM - Council of Europe), Department of Biological Standardisation (TBC)

Jose Drabwell, Past President and Member of the Board — International Patient Organisation for Primary Immunodeficiencies (IPOPI)

Stefaan van der Spiegel, Head of Sector, Substances of Human Origin — DG for Health and Food Safety (SANTE), European Commission

Martina Brix-Zuleger, Commissioner, Department VIII/C/1 Blood, Tissues and Cells — Austrian Ministry of Health   (TBC)

Matthias Gessner, Chair European Plasma Alliance, Head Takeda BioLife Plasma Europe Operations

1045-1130 Networking Break
1130-1300 Session 2: Plasma Collection: A German success story
Chair: Stephan Walsemann,
Managing Director & Medical Director — Scinomed Germany (Former Chair of the European Plasma Alliance)
 

Presentation 2: Particularities of the German System
Svenja Tatjana Barckhausen, Senior Director, Plasma Alliance Operations and Protein Procurement — Biotest

Franz Weinauer, Managing Director, Blood Collection Service — Bavarian Red Cross

1300-1415 Networking Lunch
1415-1545 Session 3: Access to Care in Europe
Chair: Brian Maguire, Journalist / Producer — Euractiv 
 

Lieven Annemans, Senior Professor in Health Economics — Ghent University

Philippe Van Wilder, Professor in health economics and HTA — Ecole de Santé Publique — Université Libre de Bruxelles

Martine Pergent, President — IPOPI

Adrian Górecki, President & Founder — EDUinstitute.org

Marianna Cavazza — University Bocconi, Italy (TBC)

Tomasz Kluszczynski, Consultant — Vintura

Maarten Van Baelen, Executive Director Europe — PPTA

1545-1615 Networking Break
1615-1730 Session 4: Hemophilia Care in Europe: “Care for Rare”
Chair: Sibylle Barden, Executive Director Barden Publishing
 

Marion Wilkens, President — Alpha1 Deutschland

Christine Keipert, Head of the Office of the German Hemophilia Registry, Section Coagulation Products — Paul-Ehrlich-Institut (PEI)

Volker Wahn, Senior Consultant, Department of Pediatrics — Charité, Berlin

Alessandro Gringeri, Chief Medical and R&D Officer — Kedrion

1730-1740 Closing remarks
Karen Etchberger, Chair, PPTA Global Board of Directors; Head of Digital Transformation & Execution Systems — CSL Behring (TBC)
1740-1750 Presentation of the HILFENHAUS AWARD
1750-1915 Networking Reception
 

DAY TWO: 2 OCTOBER 2020

 0900-0930  Opening
 

Welcome
Oliver Schmitt, Chair, PPTA European Board of Directors; General Manager — CSL Behring (TBC)

Keynote address
Dr. Yuyun Maryuningsigh, Team Lead for Blood and Other Products of Human Origin — World Health Organization

0930-1045 Session 5: Innovation
Chair: Dominika Misztela, Senior Director, Regulatory Policy Europe — PPTA
 

Research and innovation in the EU — Set-up and possible links to blood and blood components
Stefaan van der Spiegel, Head of Sector, Substances of Human Origin — DG for Health and Food Safety (SANTE), European Commission (TBC)

The untapped potential of plasma-derived proteins   (Sponsored presentation)
Christopher Morabito, Head of R&D, Plasma-Derived Therapies — Takeda (TBC)

Technical innovations for large-scale plasma processing     (Sponsored presentation)
Dieter Fassnacht, Senior Director — Grifols Process Engineering 

Innovation in Primary Immune Deficiencies: The vision of patients
Andrea Gressani, Vice President — Associazone Immunodeficienze Primitive

1045-1130 Networking Break
1130-1300 Session 6:  Hyperimmune globulins in Europe needs, policies, manufacturing and the future
Chair: Larisa Cervenakova, Medical Director  PPTA
 

COVID-19 Convalescent Plasma (CCP) donation and transfusion – European Commission guidance and database
European Commission, B4 unit (Substances of Human Origin) (TBC)

Hyperimmunoglobulins: A European dilemma from a German perspective
Uta Buckpesch-Heberer, Senior Clinical Assessor, Polyclonal and Monoclonal Antibodies — Paul-Ehrlich-Institut (PEI)

Hyperimmunes in Europe: Perspectives from a North American Hyperimmune manufacturer
Emergent BioSolutions Canada (TBC)

Emerging viruses, and hyperimmune plasma products for prevention and treatment of infectious diseases
Thomas R. Kreil, Associate Professor of Virology; Vice President, Global Pathogen Safety — Takeda

1300-1400 Networking Lunch
1430-1445 Closure of IPPC 2020
Maarten Van Baelen, Executive Director Europe — PPTA
 

[Program and speakers are subject to change]

Additional Information

SUPPORTING ORGANIZATIONS
Alpha 1 Foundation 25th logo AFNP Logo QUAD EPODIN
GBS/CIDP HAEi ITP
IPOPI signature PIDUK logo strap1 WFH logo EN RGB highres 

Congress Contacts

Hotel and Congress
inquiries:

Melanie Conrads or +32.2.724.0188
Registration
inquiries:

Charon Smith or +1.443.433.1114
Sponsorship and Exhibit 
inquiries:
Michelle Mason or +1.443.433.1106
Copyright © 2020 PPTA. All rights reserved. (202) 789-3100